by David Wallace 2024 Patients Are Asking, Episode 2 In this MPN expert interview, Dr. Gaby Hobbs shares her expertise on the various treatment options for Polycythemia Vera (PV). She explains first-line therapies, including phlebotomy, hydroxyurea, interferon (Besremi), Jakafi and highlights the importance of individualized treatment based on patient-specific factors. Watch the full interview to […]
by David Wallace 2024 Patients Are Asking, Episode 1 In our ongoing effort to provide the latest insights and resources for the MPN community, we’re excited to share an informative video on tailoring JAK inhibitor treatment strategies for myelofibrosis. Our interview with MPN expert, Dr. Lucia Masarova covers important aspects of JAK inhibitors, their role […]
by David Wallace ASH 2023 Highlights: Patients Are Asking, Episode 3 Discover the latest MPN research from the ASH 2023 conference with MPN expert, Dr. Lucia Masarova. We cover the latest clinical trials, breakthrough treatments, and innovative approaches to MPN blood cancers. Learn about combination treatments for myelofibrosis and updates on clinical trials for polycythemia […]
by David Wallace Patients Are Asking – Episode 1 In this interview with MPN specialist, Dr. Ghaith Abu-Zeinah, we learn what the term “disease modification” means. We discuss promising late-stage clinical trials and the importance of tracking your symptoms to discuss with your physician. David Wallace, PV Reporter, is your host and patient advocate. […]
by David Wallace Patients are Asking – MPN Specialist Dr. Srdan Verstovsek – Episode 3 of 3 Interview with MPN expert, Dr. Srdan Verstovsek from ASH 2022. Learn about an exciting new anti-mutant calreticulin (CALR) targeted monoclonal antibody that may lead to a molecular response in MF and ET. What were some of the highlights […]
by David Wallace Patients are Asking – Episode 2 of 3 In this interview with MPN expert, Dr. Angela Fleischman, we discuss the latest treatments for myelofibrosis (MF) and when a clinical trial should be considered. Research has linked MPNs to a pre-disposition to auto-immune disorders such as Lupus, Crohn’s disease and Psoriasis just to […]
by David Wallace Patients are Asking – MPN Specialist Dr. Michael Grunwald, from Levine Cancer Institute discusses new medications for myeloproliferative neoplasms Episode 1 of 3 Dr. Grunwald also provides insight into how to get a referral to see an MPN expert. Featuring: Dr. Michael Grunwald Thank you to our Sponsors
Episode 1 of 3 in Patients are Asking Series Episode 1 of 3 What symptoms should I look for to see if I might be progressing from polycythemia vera to myelofibrosis? When would you typically recommend Next Generation Sequencing (NGS) and what are the benefits? Why does bone & joint pain occur and what are some […]
Site by: Kaleidoscopic
